Acadia Pharmaceuticals Inc. · NASDAQ:ACAD

BlackRock, Inc. reported a 11.90% stake in Acadia Pharmaceuticals Inc. (Schedule 13G/A)

Event Jan 31, 2025 · Filed Feb 7, 2025

BlackRock, Inc. reported a 11.90% stake in Acadia Pharmaceuticals Inc., 19,878,746 shares, as a passive investor on Jan 31, 2025. Filed Feb 7, 2025 (Schedule 13G/A).

Stake
11.90%
Shares
19,878,746
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
BlackRock, Inc.11.90%19,878,746

Source

View original at SEC

Related